Allowed
Note: PharmaLink has compiled the information below for reference only. State dispensing regulations change frequently and we recommend consulting an attorney or your state medical or pharmacy board with specific questions or to verify your eligibility to dispense.
Florida permits in-office dispensing, but it is one of the more tightly administered states, requiring official registration as a dispensing practitioner on the provider’s medical license. Additionally, the controlled substance restrictions are stricter than in most of the country.
Who may dispense
Licensed practitioners, including MDs, DOs, podiatrists, dentists, and optometrists, may dispense medicinal drugs directly to their own patients once they hold a dispensing practitioner registration. Dispensing is defined broadly and covers selling medicinal drugs to a patient in the office, not merely handing over manufacturer samples.
Physicians may also delegate dispensing duties to a registered physician assistant by filing the appropriate form with the Florida Department of Health. The supervising physician remains responsible for compliance.
Registration
Practitioners must register with the Florida Department of Health as a “dispensing practitioner” before dispensing anything. The fee is currently $100, and the registration renews on the same biennial cycle as the underlying professional license. Practitioners may not dispense until the application has been approved.
Controlled substances
Florida is more restrictive here than most states. Section 465.0276 provides that a practitioner registered under it may not dispense a controlled substance listed in Schedule II or Schedule III. Schedule IV and V dispensing is permitted for registered practitioners.
The statute carves out a short list of exceptions, including dispensing incident to a surgical procedure, approved clinical trials, medication-assisted treatment facilities, and buprenorphine for the treatment of opiate addiction. The surgical exception is quantity-limited: for acute pain the supply may not exceed three days, extended to seven days only where the statutory conditions are met.
These exceptions are narrow and fact-specific, so confirm your own eligibility against the current text of the statute before dispensing any Schedule II or III product.
PDMP reporting
Each controlled substance dispensed in Schedules II through V must be reported to E-FORCSE, Florida’s Prescription Drug Monitoring Program. Reports are due no later than the close of business on the day after the drug is dispensed. PharmaLink’s dispensing software can handle the reporting for you.
Sourcing, labeling, and inspection
Drugs dispensed from the office must be purchased from a wholesaler or distributor licensed in Florida. The dispensing area must be clean, secure, and suitable for the purpose, and each container must carry a label meeting state requirements. Dispensing practitioners are subject to inspection by the Department of Health, and violations can carry fines along with suspension or permanent revocation of dispensing privileges.
Dispensing in Florida with PharmaLink
Dispensing medications to your patients offers meaningful benefits: additional practice revenue, better medication adherence, greater convenience for patients, and fewer pharmacy callbacks for your staff. PharmaLink provides the dispensing software, equipment, and support — so most practices can start dispensing within days of completing their application. PharmaLink does not sell, source, or ship medications; your practice purchases those directly from suppliers you select, under your own licenses.
- Cash & carry dispensing — patients pay at the point of care with transparent pricing.
- Workers' comp dispensing — treat injured workers, with claim data captured for your billing partner.
- Private insurance dispensing — adjudicate claims to your patients' insurance plans.
- Mail order & home delivery — send prescriptions to a fulfillment pharmacy that ships directly to your patients.
If you plan to dispense controlled substances, PharmaLink's software automatically reports to state PDMPs in all states where we operate.